Home HIV Medicine	FAQ Unsubscribe Change Email Policy About	Flying Publisher
	New: InfluenzaReport.com A Medical Textbook, 250 pages

Bladder Cancer, February 2006 Free Subscription Abstracts Retrieve all available abstracts of the following 136 articles: HTML format

Single Articles

1. KIEMENEY LA , Kuiper RP, Pfundt R, van Reijmersdal S, et al
   No Evidence For Large-scale Germline Genomic Aberrations in Hereditary Bladder Cancer Patients with High-Resolution Array-Based Comparative Genomic Hybridization.
   Cancer Epidemiol Biomarkers Prev. 2006;15:180-3.
   Abstract     Related articles   
   
   
   
   

2. ZAGHLOUL MS
   Adjuvant radiation therapy for muscle-invasive bladder cancer.
   Tunis Med. 2005;83 Suppl 12:92-3.
   Abstract     Related articles   
   
   
   
   

3. UNDERWOOD W 3RD , Dunn RL, Williams C, Lee CT, et al
   Gender and Geographic Influence on the Racial Disparity in Bladder Cancer Mortality in the US.
   J Am Coll Surg. 2006;202:284-90.
   Abstract     Related articles   
   
   Abstract available
   
   

4. BILSLAND AE , Fletcher-Monaghan A, Keith WN
   Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy.
   Neoplasia. 2005;7:1020-9.
   Abstract     Related articles   
   
   Abstract available
   
   

5. PALOU REDORTA J , Autran AM, Martinez Rodriguez RH, Huguet Perez J, et al
   [Percutaneous treatment with BCG in multiple upper tract transitional cell carcinoma]
   Actas Urol Esp. 2005;29:787-90.
   Abstract     Related articles   
   
   Abstract available
   
   

6. PASTOR GUZMAN JM , Donate Moreno MJ, Gimenez Bachs JM, Pastor Navarro H, et al
   [Entero-neobladder ileal fistula: two cases report]
   Actas Urol Esp. 2005;29:782-6.
   Abstract     Related articles   
   
   Abstract available
   
   

7. CUTTS B
   Developing and implementing a new bladder irrigation chart.
   Nurs Stand. 2005;20:48-52.
   Abstract     Related articles   
   
   Abstract available
   
   

8. CRAUSAZ S , Metcalfe S
   PHARMAC's response on gemcitabine and transparency.
   N Z Med J. 2005;118:U1741.
   Abstract     Related articles   
   
   
   
   

9. SIMPSON A
   What's happening in PHARMAC--where do all the submissions go? On the trail of gemcitabine.
   N Z Med J. 2005;118:U1733.
   Abstract     Related articles   
   
   Abstract available
   
   

10. HJELDE A , Gederaas OA, Krokan HE, Brubakk AO, et al
    Lack of effect of hyperoxia on photodynamic therapy and lipid peroxidation in three different cancer cell lines.
    Med Sci Monit. 2005;11:BR351-6.
    Abstract     Related articles   
    
    Abstract available
    
    

11. AMIEL GE , Lerner SP
    Combining surgery and chemotherapy for invasive bladder cancer: current and future directions.
    Expert Rev Anticancer Ther. 2006;6:281-91.
    Abstract     Related articles   
    
    Abstract available
    
    

12. FOKDAL L , Hoyer M, von der Maase H
    Radical radiotherapy for urinary bladder cancer: treatment outcomes.
    Expert Rev Anticancer Ther. 2006;6:269-79.
    Abstract     Related articles   
    
    Abstract available
    
    

13. SHIFF C , Veltri R, Naples J, Quartey J, et al
    Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana.
    Trans R Soc Trop Med Hyg. 2006;.
    Abstract     Related articles   
    
    Abstract available
    
    

14. CIANCIULLI AM , Merola R, Vico E, Orlandi G, et al
    Accumulation of genetic changes during the development and progression of bladder cancer.
    Pathologica. 2005;97:177-8.
    Abstract     Related articles   
    
    
    
    

15. LOPEZ-ABENTE G , Aragones N, Ramis R, Hernandez-Barrera V, et al
    Municipal distribution of bladder cancer mortality in Spain: Possible role of mining and industry.
    BMC Public Health. 2006;6:17.
    Abstract     Related articles   
    
    Abstract available
    
    

16. SHAPLYGIN LV , Furashov DV, Skorobogatyi ITs, Deviatov AS, et al
    [The radical cystectomy with different methods of the urine derivation in urinary bladder carcinoma]
    Voen Med Zh. 2005;326:31-5.
    Abstract     Related articles   
    
    
    
    

17. POLITI EN , Lazaris AC, Lambropoulou S, Alexopoulou D, et al
    Epidermal growth factor receptor and proliferating cell nuclear antigen expression in urine ThinPrep specimens.
    Cytopathology. 2005;16:303-8.
    Abstract     Related articles   
    
    Abstract available
    
    

18. KARAGUZHIN SG , Merinov DS, Martov AG
    [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia]
    Urologiia. 2005;:17-21.
    Abstract     Related articles   
    
    Abstract available
    
    

19. KUROSAKA S , Irie A, Mizoguchi H, Okuno N, et al
    Advanced clear-cell adenocarcinoma of the bladder successfully treated by radical surgery with adjuvant chemoradiotherapy.
    Int J Clin Oncol. 2005;10:362-5.
    Abstract     Related articles   
    
    Abstract available
    
    

20. FABBRI F , Brigliadori G, Ulivi P, Tesei A, et al
    Pro-apoptotic effect of a nitric oxide-donating NSAID, NCX 4040, on bladder carcinoma cells.
    Apoptosis. 2005;10:1095-103.
    Abstract     Related articles   
    
    Abstract available
    
    

21. GALLO L , Perdona S, Autorino R, Celentano E, et al
    Recovery of erection after pelvic urologic surgery: our experience.
    Int J Impot Res. 2005;17:484-93.
    Abstract     Related articles   
    
    Abstract available
    
    

22. WU X , Gu J, Grossman HB, Amos CI, et al
    Bladder Cancer Predisposition: A Multigenic Approach to DNA-Repair and Cell-Cycle-Control Genes.
    Am J Hum Genet. 2006;78:464-79.
    Abstract     Related articles   
    
    Abstract available
    
    

23. OSBORNE T
    Accurate urine telomerase test for detecting bladder cancer.
    Nat Clin Pract Oncol. 2006;3:69.
    Abstract     Related articles   
    
    
    
    

24. SUGIONO M , Hammonds JC
    Do patients with frank haematuria referred under the two-week rule have a higher incidence of bladder cancer?
    Ann R Coll Surg Engl. 2006;88:26.
    Abstract     Related articles   
    
    
    
    

25. POS FJ , Hulshof M, Lebesque J, Lotz H, et al
    Adaptive radiotherapy for invasive bladder cancer: A feasibility study.
    Int J Radiat Oncol Biol Phys. 2006;64:862-8.
    Abstract     Related articles   
    
    Abstract available
    
    

26. FUESSEL S , Herrmann J, Ning S, Kotzsch M, et al
    Chemosensitization of bladder cancer cells by survivin-directed antisense oligodeoxynucleotides and siRNA.
    Cancer Lett. 2006;232:243-54.
    Abstract     Related articles   
    
    Abstract available
    
    

27. PENG CC , Chen KC, Peng RY, Su CH, et al
    Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts.
    Cancer Lett. 2006;.
    Abstract     Related articles   
    
    Abstract available
    
    

28. KANG JU , Koo SH, Jeong TE, Kwon KC, et al
    Multitarget fluorescence in situ hybridization and melanoma antigen genes analysis in primary bladder carcinoma.
    Cancer Genet Cytogenet. 2006;164:32-8.
    Abstract     Related articles   
    
    Abstract available
    
    

29. HARTMANN A , Junker K, Dietmaier W, Schroder S, et al
    Molecular evidence for progression of nephrogenic metaplasia of the urinary bladder to clear cell adenocarcinoma.
    Hum Pathol. 2006;37:117-20.
    Abstract     Related articles   
    
    Abstract available
    
    

30. SKALKOS D , Stavropoulos NE, Tsimaris I, Gioti E, et al
    The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells.
    Planta Med. 2005;71:1030-5.
    Abstract     Related articles   
    
    Abstract available
    
    

31. REZNEK RH , Sahdev A
    MR imaging in cervical cancer: seeing is believing: The 2004 Mackenzie Davidson Memorial Lecture.
    Br J Radiol 2005;78.
    Abstract     Related articles   
    
    
    
    

32. YAQOOB N , Kayani N, Piryani J, Sulaiman MN, et al
    Lymphoepithelioma-like carcinoma of urinary bladder: (LELCA).
    J Pak Med Assoc. 2005;55:402-3.
    Abstract     Related articles   
    
    Abstract available
    
    

33. WIDENGREN J , Thyberg P
    FCS cell surface measurements--photophysical limitations and consequences on molecular ensembles with heterogenic mobilities.
    Cytometry A. 2005;68:101-12.
    Abstract     Related articles   
    
    Abstract available
    
    

34. MADDOX JM , Anderson JA, Plews D, Ludlam CA, et al
    Management of acquired von Willebrand's syndrome in a patient requiring major surgery.
    Haemophilia. 2005;11:633-7.
    Abstract     Related articles   
    
    Abstract available
    
    

35. MITROPOULOS D , Kiroudi-Voulgari A, Nikolopoulos P, Manousakas T, et al
    Accuracy of cystoscopy in predicting histologic features of bladder lesions.
    J Endourol. 2005;19:861-4.
    Abstract     Related articles   
    
    Abstract available
    
    

36. CUI L , Shi Y, Dai G, Pan H, et al
    Modification of N-Methyl-N-Nitrosourea initiated bladder carcinogenesis in Wistar rats by terephthalic acid.
    Toxicol Appl Pharmacol. 2006;210.
    Abstract     Related articles   
    
    Abstract available
    
    

37. LOPEZ-BELTRAN A , Requena M, Luque R, Alvarez-Kindelan J, et al
    Cyclin D3 expression in primary Ta/T1 bladder cancer.
    J Pathol. 2006;.
    Abstract     Related articles   
    
    Abstract available
    
    

38. SCHULTZ IJ , Witjes JA, Swinkels DW, de Kok JB, et al
    Bladder cancer diagnosis and recurrence prognosis: Comparison of markers with emphasis on survivin.
    Clin Chim Acta. 2006;.
    Abstract     Related articles   
    
    Abstract available
    
    

39. TONOLI S , Bertoni F, De Stefani A, Vitali E, et al
    Radical radiotherapy for bladder cancer: retrospective analysis of a series of 459 patients treated in an Italian institution.
    Clin Oncol (R Coll Radiol). 2006;18:52-9.
    Abstract     Related articles   
    
    Abstract available
    
    

40. ABDEL-LATIF M
    Which clinical variables are associated with lymph node metastases in patients with superficial bladder cancer?
    Nat Clin Pract Urol. 2005;2:214-5.
    Abstract     Related articles   
    
    
    
    

41. 
    Thermo-chemotherapy for bladder cancer.
    Nat Clin Pract Urol. 2005;2:208-9.
    Abstract     Related articles   
    
    
    
    

42. 
    Protein profiling of urine in the diagnosis of bladder cancer.
    Nat Clin Pract Urol. 2005;2:207-8.
    Abstract     Related articles   
    
    
    
    

43. ZHANG J
    Can ferumoxtran-10-enhanced MRI be used for preoperative nodal staging in patients with bladder cancer?
    Nat Clin Pract Urol. 2005;2:168-9.
    Abstract     Related articles   
    
    
    
    

44. 
    Systemic inflammatory response is a prognostic factor in bladder cancer.
    Nat Clin Pract Urol. 2005;2:154.
    Abstract     Related articles   
    
    
    
    

45. MELLON JK
    Can nomograms using urinary NMP22 predict recurrence and progression of superficial bladder cancer?
    Nat Clin Pract Urol. 2005;2:370-1.
    Abstract     Related articles   
    
    
    
    

46. 
    RON and MET co-expression is a prognostic indicator in bladder cancer patients.
    Nat Clin Pract Urol. 2005;2:363.
    Abstract     Related articles   
    
    
    
    

47. 
    EGFR and HER2 expression predict outcome of muscle-invading bladder cancers.
    Nat Clin Pract Urol. 2005;2:358.
    Abstract     Related articles   
    
    
    
    

48. 
    On-the-spot test for bladder cancer superior to urinary cytology.
    Nat Clin Pract Urol. 2005;2:120.
    Abstract     Related articles   
    
    
    
    

49. 
    Advances in preoperative nodal staging for bladder cancer.
    Nat Clin Pract Urol. 2005;2:68-69.
    Abstract     Related articles   
    
    
    
    

50. WOLFF EM , Liang G, Jones PA
    Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.
    Nat Clin Pract Urol. 2005;2:502-10.
    Abstract     Related articles   
    
    Abstract available
    
    

51. OSBORNE T
    A reduced chemotherapy regimen for bladder cancer.
    Nat Clin Pract Urol. 2005;2:468.
    Abstract     Related articles   
    
    
    
    

52. KYME C
    No increased risk of bladder cancer after prostate cancer radiation therapy.
    Nat Clin Pract Urol. 2005;2:467-8.
    Abstract     Related articles   
    
    
    
    

53. OSBORNE T
    Powerful new markers for invasive bladder cancer.
    Nat Clin Pract Urol. 2005;2:522.
    Abstract     Related articles   
    
    
    
    

54. LOVEGROVE C
    A role for death receptors in BCG therapy for bladder cancer?
    Nat Clin Pract Urol. 2005;2:522.
    Abstract     Related articles   
    
    
    
    

55. GARCIA JA , Dreicer R
    Adjuvant and neoadjuvant chemotherapy for bladder cancer: management and controversies.
    Nat Clin Pract Urol. 2005;2:32-7.
    Abstract     Related articles   
    
    Abstract available
    
    

56. VAN DER MEIJDEN AP
    Does hexaminolevulinate imaging improve the detection and treatment of bladder cancer?
    Nat Clin Pract Urol. 2006;3:22-3.
    Abstract     Related articles   
    
    
    
    

57. OSBORNE T
    Accurate urine telomerase test for detecting bladder cancer.
    Nat Clin Pract Urol. 2006;3:7.
    Abstract     Related articles   
    
    
    
    

58. LEONARDO C , Merola R, Orlandi G, Leonardo F, et al
    C-erb-2 gene amplification and chromosomal anomalies in bladder cancer: preliminary results.
    J Exp Clin Cancer Res. 2005;24:633-8.
    Abstract     Related articles   
    
    Abstract available
    
    

59. SHIMASAKI N , Kuroda N, Miyazaki E, Hayashi Y, et al
    The distribution pattern of myofibroblasts in the stroma of human bladder carcinoma depends on their invasiveness.
    Histol Histopathol. 2006;21:349-53.
    Abstract     Related articles   
    
    Abstract available
    
    

60. FECHNER G , Siener R, Reimann M, Kobalz L, et al
    Randomised phase II trial of gemcitabine and paclitaxel second-line chemotherapy in patients with transitional cell carcinoma (AUO Trial AB 20/99).
    Int J Clin Pract. 2006;60:27-31.
    Abstract     Related articles   
    
    Abstract available
    
    

61. QUINTERO A , Alvarez-Kindelan J, Luque RJ, Gonzalez-Campora R, et al
    Ki-67 MIB1 labelling index and the prognosis of primary TaT1 urothelial cell carcinoma of the bladder.
    J Clin Pathol. 2006;59:83-8.
    Abstract     Related articles   
    
    Abstract available
    
    

62. LOUDA M , Vokurkova D, Simakova E
    [Apoptosis of urothelial carcinoma cells]
    Cas Lek Cesk. 2005;144:817-20.
    Abstract     Related articles   
    
    Abstract available
    
    

63. POLLERA CF , Nelli F
    Developing innovative strategies for advanced transitional cell carcinoma of the bladder.
    Expert Rev Anticancer Ther. 2006;6:83-92.
    Abstract     Related articles   
    
    Abstract available
    
    

64. ROZET F , Harmon J, Arroyo C, Cathelineau X, et al
    Benefits of laparoscopic prostate-sparing radical cystectomy.
    Expert Rev Anticancer Ther. 2006;6:21-6.
    Abstract     Related articles   
    
    Abstract available
    
    

65. NISHIMOTO K , Oyama M, Ando T, Nakajima Y, et al
    [Inguinal lymph node metastasis of bladder carcinoma ten years after cystourethrectomy: a case report]
    Hinyokika Kiyo. 2005;51:759-61.
    Abstract     Related articles   
    
    Abstract available
    
    

66. YOSHIDA S , Hayashi T, Yoshinaga A, Ohno R, et al
    [A stage-dependent follow-up strategy after radical cystectomy for bladder carcinoma]
    Hinyokika Kiyo. 2005;51:727-30.
    Abstract     Related articles   
    
    Abstract available
    
    

67. TSURUKAWA H , Komura H, Hirata T
    [Solitary fibrous tumor presenting as perivesical mass associated with hypoglycemia: a case report]
    Nippon Hinyokika Gakkai Zasshi. 2005;96:709-13.
    Abstract     Related articles   
    
    Abstract available
    
    

68. MATSUMOTO T , Iida M
    [Extra-gastric lymphoma of MALT type and H. pylori eradication]
    Nippon Rinsho. 2005;63 Suppl 11:308-11.
    Abstract     Related articles   
    
    
    
    

69. AHMED HU , Arya M, Patel HR
    Bladder carcinoma: understanding advanced and metastatic disease with potential molecular therapeutic targets.
    Expert Rev Anticancer Ther. 2005;5:1011-22.
    Abstract     Related articles   
    
    Abstract available
    
    

70. LEE YY , Muchhal K, Chan CK, Cheung AS, et al
    Levobupivacaine and fentanyl for spinal anaesthesia: a randomized trial.
    Eur J Anaesthesiol 2005;22:899-903.
    Abstract     Related articles   
    
    Abstract available
    
    

71. ANGELETTI C , Harvey NR, Khomitch V, Fischer AH, et al
    Detection of malignancy in cytology specimens using spectral-spatial analysis.
    Lab Invest. 2005;85:1555-64.
    Abstract     Related articles   
    
    Abstract available
    
    

72. HARTH V , Bolt HM, Bruning T
    Cancer of the urinary bladder in highly exposed workers in the production of dinitrotoluenes: a case report.
    Int Arch Occup Environ Health. 2005;78:677-80.
    Abstract     Related articles   
    
    Abstract available
    
    

73. SAWHNEY R , Bourgeois D, Chaudhary UB
    Neo-adjuvant chemotherapy for muscle-invasive bladder cancer: a look ahead.
    Ann Oncol. 2006;.
    Abstract     Related articles   
    
    Abstract available
    
    

74. YAMADA T , Tsuchiya T, Kamei S, Yoh M, et al
    [Analysis of factors affecting reccurence and prognosis of superficial bladder cancer--study of 800 patients--]
    Nippon Hinyokika Gakkai Zasshi. 2006;97:33-41.
    Abstract     Related articles   
    
    Abstract available
    
    

75. CLAIROTTE A , Lascombe I, Fauconnet S, Mauny F, et al
    Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors.
    Am J Clin Pathol. 2006;125:119-26.
    Abstract     Related articles   
    
    Abstract available
    
    

76. TINKER A , Winquist E, Canil C, Moore M, et al
    A phase I dose finding study of cisplatin, gemcitabine, and weekly docetaxel for patients with advanced transitional cell cancer.
    Am J Clin Oncol. 2006;29:3-7.
    Abstract     Related articles   
    
    Abstract available
    
    

77. HE LF , Guan KP, Ye HY, Ren L, et al
    Heat shock protein 70 expression in relation to apoptosis in primary bladder transitional cell carcinoma.
    Chin Med J (Engl). 2005;118:2093-6.
    Abstract     Related articles   
    
    
    
    

78. HENG HG , Lowry JE, Boston S, Gabel C, et al
    Smooth muscle neoplasia of the urinary bladder wall in three dogs.
    Vet Radiol Ultrasound. 2006;47:83-6.
    Abstract     Related articles   
    
    Abstract available
    
    

79. PARWANI AV , Herawi M, Volmar K, Tsay SH, et al
    Urothelial carcinoma with rhabdoid features: report of 6 cases.
    Hum Pathol. 2006;37:168-72.
    Abstract     Related articles   
    
    Abstract available
    
    

80. DENZINGER S , Mohren K, Knuechel R, Wild PJ, et al
    Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Hum Pathol. 2006;37:143-51.
    Abstract     Related articles   
    
    Abstract available
    
    

81. KISHORE TA , Bhat S, Albert AS, Augustine J, et al
    Sarcomatoid carcinoma in a bladder diverticulum--a rare case.
    Indian J Med Sci. 2005;59:543-5.
    Abstract     Related articles   
    
    
    
    

82. PASALEGA M , Calota F, Paraliov T, Mesina C, et al
    [Crohn's disease. Clinical and therapeutical considerations]
    Chirurgia (Bucur). 2005;100:495-502.
    Abstract     Related articles   
    
    Abstract available
    
    

83. ROMANENKO A , Morimura K, Kinoshita A, Wanibuchi H, et al
    Aberrant expression of E-cadherin and beta-catenin in association with transforming growth factor-beta1 in urinary bladder lesions in humans after the Chernobyl accident.
    Cancer Sci. 2006;97:45-50.
    Abstract     Related articles   
    
    Abstract available
    
    

84. COWLED P , Kanter I, Leonardos L, Jackson P, et al
    Uroplakin Ib gene transcription in urothelial tumor cells is regulated by CpG methylation.
    Neoplasia. 2005;7:1091-103.
    Abstract     Related articles   
    
    Abstract available
    
    

85. ALVAREZ ALVAREZ C , Vieites Perez-Quintela B, Pesqueira Santiago D, Santos Armentia E, et al
    [Primary non-Hodgkin large B-cell lymphoma of bladder. Report of a case]
    Actas Urol Esp. 2005;29:902-4.
    Abstract     Related articles   
    
    Abstract available
    
    

86. RODRIGUEZ-COVARRUBIAS F , Trinidad-Hernandez S, Uribe-Uribe N, Sotomayor de Zavaleta M, et al
    [Primary small cell carcinoma of the bladder treated with partial cystectomy. Case report]
    Actas Urol Esp. 2005;29:899-901.
    Abstract     Related articles   
    
    Abstract available
    
    

87. EDUARDO MATHEUS W , Nardi Pedro R, Maia Oliveira RR, Ferreira U, et al
    [Is there a place for randomized biopsies in the follow up of superficial transitional cell carcinoma of the urinary bladder?]
    Actas Urol Esp. 2005;29:842-5.
    Abstract     Related articles   
    
    Abstract available
    
    

88. VICENTE RODRIGUEZ J
    [Tactics in the bladder]
    Arch Esp Urol. 2005;58:715-7.
    Abstract     Related articles   
    
    
    
    

89. VICENTE RODRIGUEZ J
    [Tactics in the bladder]
    Arch Esp Urol. 2005;58:707-14.
    Abstract     Related articles   
    
    
    
    

90. LAGUNA MP , Lagerveld B, de la Rosette J
    [Endourologic tactics and tricks in the lower urinary tract. Instrumentation]
    Arch Esp Urol. 2005;58:703-6.
    Abstract     Related articles   
    
    
    
    

91. OWENS CL , Ali SZ
    Atypical squamous cells in exfoliative urinary cytology: clinicopathologic correlates.
    Diagn Cytopathol. 2005;33:394-8.
    Abstract     Related articles   
    
    Abstract available
    
    

92. MOHAMEDALI KA , Kedar D, Sweeney P, Kamat A, et al
    The vascular-targeting fusion toxin VEGF121/rGel inhibits the growth of orthotopic human bladder carcinoma tumors.
    Neoplasia. 2005;7:912-20.
    Abstract     Related articles   
    
    Abstract available
    
    

93. JACQUEZ GM , Kaufmann A, Meliker J, Goovaerts P, et al
    Global, local and focused geographic clustering for case-control data with residential histories.
    Environ Health. 2005;4:4.
    Abstract     Related articles   
    
    Abstract available
    
    

94. DIAMANTOPOULOU K , Lazaris A, Mylona E, Zervas A, et al
    Cyclooxygenase-2 protein expression in relation to apoptotic potential and its prognostic significance in bladder urothelial carcinoma.
    Anticancer Res. 2005;25.
    Abstract     Related articles   
    
    Abstract available
    
    

95. RIBAL MJ , Mengual L, Marin M, Algaba F, et al
    Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
    Anticancer Res. 2006;26.
    Abstract     Related articles   
    
    Abstract available
    
    

96. PANANI AD , Roussos C
    Sex chromosome abnormalities in bladder cancer: Y polysomies are linked to PT1-grade III transitional cell carcinoma.
    Anticancer Res. 2006;26.
    Abstract     Related articles   
    
    Abstract available
    
    

97. STEIN JP , Quek ML, Skinner DG
    Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors.
    BJU Int. 2006;97:232-7.
    Abstract     Related articles   
    
    
    
    

98. STEIN JP , Quek ML, Skinner DG
    Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale.
    BJU Int. 2006;97:227-31.
    Abstract     Related articles   
    
    Abstract available
    
    

99. BERGLUND RK , Matin SF, Desai M, Kaouk J, et al
    Laparoscopic radical cystoprostatectomy with bilateral nephroureterectomy: initial report.
    BJU Int. 2006;97:37-41.
    Abstract     Related articles   
    
    Abstract available
    
    

100. STEGINGA S
     100 Questions and Answers about Bladder Cancer.
     BJU Int. 2006;97:651.
     Abstract     Related articles   
     
     
     
     

101. SIDDIQUI EJ , Shabbir MA, Mikhailidis DP, Mumtaz FH, et al
     The effect of serotonin and serotonin antagonists on bladder cancer cell proliferation.
     BJU Int. 2006;97:634-9.
     Abstract     Related articles   
     
     Abstract available
     
     

102. MOSTAFID AH , Rajkumar RG, Stewart AB, Singh R, et al
     Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer.
     BJU Int. 2006;97:509-12.
     Abstract     Related articles   
     
     Abstract available
     
     

103. VOLKMER BG , Kuefer R, Bartsch G Jr, Straub M, et al
     Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival.
     Cancer. 2005;104:2384-91.
     Abstract     Related articles   
     
     Abstract available
     
     

104. CAO W , Cai L, Rao JY, Pantuck A, et al
     Tobacco smoking, GSTP1 polymorphism, and bladder carcinoma.
     Cancer. 2005;104:2400-8.
     Abstract     Related articles   
     
     Abstract available
     
     

105. SINGH AV , Franke AA, Blackburn GL, Zhou JR, et al
     Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
     Cancer Res. 2006;66:1851-8.
     Abstract     Related articles   
     
     Abstract available
     
     

106. TING AH , Jair KW, Schuebel KE, Baylin SB, et al
     Differential requirement for DNA methyltransferase 1 in maintaining human cancer cell gene promoter hypermethylation.
     Cancer Res. 2006;66:729-35.
     Abstract     Related articles   
     
     Abstract available
     
     

107. EAREL JK JR , VanOosten RL, Griffith TS
     Histone deacetylase inhibitors modulate the sensitivity of tumor necrosis factor-related apoptosis-inducing ligand-resistant bladder tumor cells.
     Cancer Res. 2006;66:499-507.
     Abstract     Related articles   
     
     Abstract available
     
     

108. KASSOUF W , Chintharlapalli S, Abdelrahim M, Nelkin G, et al
     Inhibition of bladder tumor growth by 1,1-bis(3'-indolyl)-1-(p-substitutedphenyl)methanes: a new class of peroxisome proliferator-activated receptor gamma agonists.
     Cancer Res. 2006;66:412-8.
     Abstract     Related articles   
     
     Abstract available
     
     

109. URAKAMI S , Shiina H, Enokida H, Kawakami T, et al
     Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
     Clin Cancer Res. 2006;12:383-91.
     Abstract     Related articles   
     
     Abstract available
     
     

110. MIYATA Y , Kanda S, Ohba K, Nomata K, et al
     Lymphangiogenesis and Angiogenesis in Bladder Cancer: Prognostic Implications and Regulation by Vascular Endothelial Growth Factors-A, -C, and -D.
     Clin Cancer Res. 2006;12:800-806.
     Abstract     Related articles   
     
     Abstract available
     
     

111. SYLVESTER RJ , van der Meijden AP, Oosterlinck W, Witjes JA, et al
     Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials.
     Eur Urol. 2006;.
     Abstract     Related articles   
     
     Abstract available
     
     

112. ZLOTTA AR
     NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses.
     Eur Urol. 2006;49:412.
     Abstract     Related articles   
     
     
     
     

113. WITJES JA
     Management of BCG Failures in Superficial Bladder Cancer: A Review.
     Eur Urol. 2006;.
     Abstract     Related articles   
     
     Abstract available
     
     

114. SCHRIER BP , Peters M, Barentsz JO, Witjes JA, et al
     Evaluation of Chemotherapy with Magnetic Resonance Imaging in Patients with Regionally Metastatic or Unresectable Bladder Cancer.
     Eur Urol. 2006;.
     Abstract     Related articles   
     
     Abstract available
     
     

115. LEHMANN J , Retz M, Sidhu SS, Sell M, et al
     Antitumor Activity of the Antimicrobial Peptide Magainin II against Bladder Cancer Cell Lines.
     Eur Urol. 2006;.
     Abstract     Related articles   
     
     Abstract available
     
     

116. MUTO G , Bardari F, D'Urso L
     New serosal lined antireflux ureteroileal implantation technique on a gia stapler detubularised ileal neobladder: technical considerations and results.
     Eur Urol. 2005;48:826-30.
     Abstract     Related articles   
     
     Abstract available
     
     

117. CHAMPELOVIER P , El Atifi M, Mantel F, Rostaing B, et al
     In vitro tumoral progression of human bladder carcinoma: role for TGFbeta.
     Eur Urol. 2005;48:846-51.
     Abstract     Related articles   
     
     Abstract available
     
     

118. MUNGAN MU , Canda AE, Tuzel E, Yorukoglu K, et al
     Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder.
     Eur Urol. 2005;48:760-3.
     Abstract     Related articles   
     
     Abstract available
     
     

119. HEMMINKI K , Chen B
     Parental lung cancer as predictor of cancer risks in offspring: Clues about multiple routes of harmful influence?
     Int J Cancer 2005;.
     Abstract     Related articles   
     
     Abstract available
     
     

120. AUST TR , Massey JA
     Tubercular prostatic abscess as a complication of intravesical bacillus Calmette-Guerin immunotherapy.
     Int J Urol. 2005;12:920-1.
     Abstract     Related articles   
     
     Abstract available
     
     

121. HONG SH , Seo SI, Kim JC, Hwang TK, et al
     Laparoscopic radical cystectomy with extracorporeal urinary diversion: preliminary experience.
     Int J Urol. 2005;12:869-74.
     Abstract     Related articles   
     
     Abstract available
     
     

122. SANCHEZ-CARBAYO M , Socci ND, Lozano J, Saint F, et al
     Defining Molecular Profiles of Poor Outcome in Patients With Invasive Bladder Cancer Using Oligonucleotide Microarrays.
     J Clin Oncol. 2006;.
     Abstract     Related articles   
     
     Abstract available
     
     

123. RATLIFF TL
     Free DNA in urine: a new marker for bladder cancer? Preliminary data.
     J Urol. 2006;175:787.
     Abstract     Related articles   
     
     
     
     

124. MONTIE JE
     Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling.
     J Urol. 2006;175:483-4.
     Abstract     Related articles   
     
     
     
     

125. MONTIE JE
     Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.
     J Urol. 2006;175:482-4.
     Abstract     Related articles   
     
     
     
     

126. MAHNKEN A , Kausch I, Feller AC, Kruger S, et al
     E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder.
     Oncol Rep. 2005;14:1065-70.
     Abstract     Related articles   
     
     Abstract available
     
     

127. QUIRINO R , Ornellas AA, Wisnescky A
     [Treatment of patients with recurrent superficial bladder cancer with lyophilized Moureau-Rio de Janeiro BCG strain. Brazillian National Cancer Institute experience]
     Prog Urol. 2005;15:667-73.
     Abstract     Related articles   
     
     Abstract available
     
     

128. RACIOPPI M , Porreca A, Foschi N, Delicato G, et al
     Bladder perforation: a potential risk of early endovesical chemotherapy with mitomycin C.
     Urol Int. 2005;75:373-5.
     Abstract     Related articles   
     
     Abstract available
     
     

129. JOHAL NS , Kouriefs C, Apthorp L, Plail RO, et al
     An appendicular mass mimicking a bladder tumour.
     Urol Int. 2005;75:371-2.
     Abstract     Related articles   
     
     Abstract available
     
     

130. BASSI P , De Marco V, Tavolini IM, Longo F, et al
     Pharmacokinetic study of intravesical gemcitabine in carcinoma in situ of the bladder refractory to bacillus Calmette-Guerin therapy.
     Urol Int. 2005;75:309-13.
     Abstract     Related articles   
     
     Abstract available
     
     

131. KEFER JC , Voelzke BB, Flanigan RC, Wojcik EM, et al
     Risk assessment for occult malignancy in the prostate before radical cystectomy.
     Urology. 2005;66:1251-5.
     Abstract     Related articles   
     
     Abstract available
     
     

132. TZAI TS , Tsai YS, Shiau AL, Wu CL, et al
     Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
     Urology. 2006;67:294-9.
     Abstract     Related articles   
     
     Abstract available
     
     

133. NIEDER AM , Brausi M, Lamm D, O'Donnell M, et al
     Management of stage T1 tumors of the bladder: International Consensus Panel.
     Urology. 2005;66.
     Abstract     Related articles   
     
     Abstract available
     
     

134. SYLVESTER RJ , van der Meijden A, Witjes JA, Jakse G, et al
     High-grade Ta urothelial carcinoma and carcinoma in situ of the bladder.
     Urology. 2005;66.
     Abstract     Related articles   
     
     Abstract available
     
     

135. OOSTERLINCK W , Solsona E, Akaza H, Busch C, et al
     Low-grade Ta (noninvasive) urothelial carcinoma of the bladder.
     Urology. 2005;66.
     Abstract     Related articles   
     
     Abstract available
     
     

136. LOKESHWAR VB , Habuchi T, Grossman HB, Murphy WM, et al
     Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.
     Urology. 2005;66.
     Abstract     Related articles   
     
     Abstract available